Severe Combined Immunodeficiency clinical trials at UCSD

1 in progress, 0 open to eligible people

Registry Study of Revcovi Treatment in Patients With ADA-SCID
Sorry, not currently recruiting here
This registry is conducted in patients with adenosine deaminase severe combined immune deficiency (ADA-SCID) treated with Revcovi™ to collect periodic clinical and biochemical data on safety and dose adjustment.
San Diego, California and other locations

Last updated: July 25, 2022